Neuronetics, Inc.
Formerly NEURONETICS INC
Neuronetics, Inc. is listed today as Neuronetics, Inc.: market value, financials and filings are on its company page.
Funding rounds
5 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jun 2017 | $15 M | No. 5 | $10 to $50 million | equity | SEC | |
| Apr 2015 | $34 M | No. 4 | $10 to $50 million | equity | SEC | |
| Nov 2014 | $9 M | No. 3 | $2 to $10 million | options | SEC | |
| May 2011 | $30 M | No. 2 | $10 to $50 million | equity | SEC | |
| Aug 2009 | $30 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
As the listed company Neuronetics, Inc., its revenue in fiscal 2025 came from these business segments: Clinical Services $86.98 million (58%), Medical Device $62.18 million (42%).
Annual report (SEC XBRL) · Dec 2025
Neuronetics, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2017).
SEC Form D · Jun 2017
The industry group it chose in its notices: Other Health Care.
SEC Form D · Jun 2017
Products and services#
No products or services of Neuronetics, Inc. are on record.
Investors#
7 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Brian E. Farley | Person | not stated | not stated | Held Series D, E, F and G preferred stock, director (Form 3, 2018) | SEC Form 3 |
| General Electric Co | Fund or asset manager | not stated | not stated | Held Series F and G preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| GE Ventures Ltd | Venture capital | not stated | not stated | Held Series F and G preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| Investor Growth Capital, LLC | Fund or asset manager | not stated | not stated | Held Series A-2, B, C, D, E, F and G preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| New Leaf Venture Associates II, L.P. | Venture capital | not stated | not stated | Held Series D, E, F and G preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| New Leaf Venture Management II, L.L.C. | Venture capital | not stated | not stated | Held Series D, E, F and G preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| New Leaf Ventures II, L.P. | Venture capital | not stated | not stated | Held Series D, E, F and G preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 23 investors.
Largest shareholders today
Institutions holding Neuronetics, Inc. shares, as of Sep 30, 2026.
- Madryn Asset Management, LP$43 M23.85%
- Point72 Asset Management, L.P.$10 M5.36%
- Wexford Capital LP$5 M2.58%
- Marshall Wace, LLP$4 M2.00%
- Vanguard Capital Management LLC$4 M1.97%
- Eversept Partners, LP$3 M1.80%
- Lane Generational LLC$3 M1.62%
- HighTower Advisors, LLC$3 M1.42%
- Masters Capital Management LLC$2 M1.29%
- FourWorld Capital Management LLC$2 M1.21%
- AdvisorShares Investments LLC$2 M1.19%
- Ikarian Capital, LLC$2 M1.04%
- Morgan Stanley$2 M0.97%
- Citadel Advisors LLC$1 M0.82%
- Driehaus Capital Management LLC$1 M0.75%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Anthony Pui | Executive officer | Jun 2017 |
| Cassie Hallberg | Executive officer | Jun 2017 |
| Christopher Thatcher | Executive officer | Jun 2017 |
| Greg Harper | Executive officer | Jun 2017 |
| Peter Donato | Executive officer | Jun 2017 |
| Steve MacKinnon | Executive officer | Jun 2017 |
| Christopher Sherrill Thatcher | Executive officer | May 2015 |
| Mark R. Bausinger | Executive officer | May 2015 |
| Bruce J. Shook | Executive officer | May 2011 |
| James J. Breidenstein | Executive officer | May 2011 |
| Judy J. Ways | Executive officer | May 2011 |
| Mark J. Bausinger | Executive officer | May 2011 |
| Mark J. Demitrack | Executive officer | May 2011 |
| Mark J. Riehl | Executive officer | May 2011 |
| Mary J. Hailey | Executive officer | May 2011 |
| Stanford J. Miller | Executive officer | May 2011 |
| James Breidenstein | Executive officer | Aug 2009 |
| Judy Ways | Executive officer | Aug 2009 |
| Mark Bausinger | Executive officer | Aug 2009 |
| Mark Demitrack | Executive officer | Aug 2009 |
| Mark Riehl | Executive officer | Aug 2009 |
| Peter Anastasiou | Executive officer | Aug 2009 |
| Stanford Miller | Executive officer | Aug 2009 |
| Brian Farley | Director | Jun 2017 |
| Christopher Thatcher | Director | Jun 2017 |
| Ron Hunt | Director | Jun 2017 |
| Stephen Campe | Director | Jun 2017 |
| Wilfred Jaeger | Director | Jun 2017 |
| Brian Sherrill Farley | Director | May 2015 |
| Christopher Sherrill Thatcher | Director | May 2015 |
| Kevin D. Bitterman | Director | May 2015 |
| Liam D. Ratcliffe | Director | May 2015 |
| Michael D. Dale | Director | May 2015 |
| P. Sherrill Neff | Director | May 2015 |
| Robert R. Kuhling | Director | May 2015 |
| Stephen D. Campe | Director | May 2015 |
| Wilfred D. Jaeger | Director | May 2015 |
| Bruce J. Shook | Director | May 2011 |
| Dan Sachs | Director | May 2011 |
| Kevin J. Bitterman | Director | May 2011 |
About
American company.
Went public since 2018. Its SEC number is that of a company listed on a stock exchange.